While the drug pipeline narrows, pharmaceutical companies are broadening their options by ruling nothing out. Protein crystallization technology is proving to be a ...
Monoclonal antibodies (mAbs) have revolutionized cancer therapy due to their ability to specifically target tumor cells while sparing healthy ones. These biologics have become indispensable in ...